ASND
Ascendis Pharma·NASDAQ
--
--(--)
--
--(--)
ASND Filings
Filing Date
Form Description
Form Type
2026-02-03
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-03 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-14
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-14 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-13
Form 144 - Report of proposed sale of securities
Ownership
2026-01-13 · Ownership
Form 144 - Report of proposed sale of securities
2026-01-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-12 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-09
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-09 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-10
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-10 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-04
Form 144 - Report of proposed sale of securities
Ownership
2025-12-04 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-02
Form 144 - Report of proposed sale of securities
Ownership
2025-12-02 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-02
Form 144 - Report of proposed sale of securities
Ownership
2025-12-02 · Ownership
Form 144 - Report of proposed sale of securities
